759 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Will We See an "AI Hangover" or an AI Surge in 2024? https://www.fool.com/investing/2024/01/15/will-we-see-an-ai-hangover-or-an-ai-surge-in-2024/?source=iedfolrf0000001 Jan 15, 2024 - AI stocks surged last year, but is the rally just hype?
Earnings drive Acuity Brands to top industrial gainer of week, Plug Power sees loser tag https://seekingalpha.com/news/4054872-earnings-drive-acuity-brands-to-top-industrial-gainer-of-week-plug-power-sees-loser-tag?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news Jan 13, 2024 - The Industrial Select Sector (XLI) climbed +0.61% for the week ending Jan. 12, while the SPDR S&P 500 Trust ETF (SPY) rose +1.87%. Read more here
Okta (OKTA) Sees a More Significant Dip Than Broader Market: Some Facts to Know https://www.zacks.com/stock/news/2209181/okta-okta-sees-a-more-significant-dip-than-broader-market-some-facts-to-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2209181 Jan 11, 2024 - In the most recent trading session, Okta (OKTA) closed at $83.78, indicating a -0.2% shift from the previous trading day.
ConocoPhillips (COP) Sees a More Significant Dip Than Broader Market: Some Facts to Know https://www.zacks.com/stock/news/2209154/conocophillips-cop-sees-a-more-significant-dip-than-broader-market-some-facts-to-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2209154 Jan 11, 2024 - In the most recent trading session, ConocoPhillips (COP) closed at $111, indicating a -0.16% shift from the previous trading day.
NIO Inc. (NIO) Sees a More Significant Dip Than Broader Market: Some Facts to Know https://www.zacks.com/stock/news/2209143/nio-inc-nio-sees-a-more-significant-dip-than-broader-market-some-facts-to-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2209143 Jan 11, 2024 - The latest trading day saw NIO Inc. (NIO) settling at $7.40, representing a -0.13% change from its previous close.
Novo Nordisk CEO sees Wegovy users sticking with drug: report https://seekingalpha.com/news/4054131-novo-nordisk-ceo-sees-wegovy-users-sticking-with-drug-report?source=feed_sector_healthcare Jan 10, 2024 - Novo Nordisk's CEO reportedly expects patients to stick with Wegovy longer than they would if they were taking an older weight-loss medication. Read more here.
U.S. Stocks Seeing Modest Strength As Inflation Data Looms https://www.rttnews.com/story.aspx?Id=3415976 Jan 10, 2024 - Stocks have moved modestly higher during trading on Wednesday, with the major averages all moving to the upside following the mixed performance seen in the previous session. The tech-heavy Nasdaq reached a new high for the session in recent trading. The modest strength on Wall Street may reflect optimism ahead to the release of key U.S. inflation data in the comings days.
Here's what Wall Street wants to see from Hollywood this year https://www.cnbc.com/2024/01/10/what-wall-street-wants-to-see-from-hollywood-in-2024.html Jan 10, 2024 - Wall Street wants legacy media companies to prove that streaming can be a profitable model, but it has yet to be convinced.
Wall Street Analysts See Micron (MU) as a Buy: Should You Invest? https://www.zacks.com/stock/news/2207879/wall-street-analysts-see-micron-mu-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2207879 Jan 09, 2024 - According to the average brokerage recommendation (ABR), one should invest in Micron (MU). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Wall Street Analysts See a 133.85% Upside in Evolus, Inc. (EOLS): Can the Stock Really Move This High? https://www.zacks.com/stock/news/2207926/wall-street-analysts-see-a-133-85-upside-in-evolus-inc-eols-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2207926 Jan 09, 2024 - The consensus price target hints at a 133.9% upside potential for Evolus, Inc. (EOLS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Pages: 1...6364656667686970717273...76

<<<Page 68>